The ClearSight system is a noninvasive solution that offers you proactive decision support to optimize perfusion. The ClearSight system provides advanced hemodynamic parameters and continuous noninvasive blood pressure (BP) from a finger cuff.
The ClearSight system extends the benefits of continuous hemodynamic monitoring to a broad patient population, including patients in whom an arterial line would not typically be placed.1-3
Continuous noninvasive blood pressure (BP) from a noninvasive finger cuff in addition to key advanced hemodynamic parameters.
Noninvasive hemodynamic monitoring offered by the ClearSight system provides information to enable you to make proactive clinical decisions across the continuum of care, including moderate- to high-risk surgery patients, and can also be utilized perioperatively to manage patients’ changing clinical situations.
The ClearSight system connects to your patient’s finger. Upon starting a measurement, the finger cuff can be used and re-applied for up to 72 hours on one patient. After 8 hours of continuous monitoring on a single finger, the finger cuff should be re-applied to another finger.
To increase comfort, two ClearSight finger cuffs may be connected simultaneously to alternate the measurement between two fingers. This allows uninterrupted continuous monitoring up to 72 hours.
|ClearSight Finger Cuff Small Multi Pack||CSCS|
|ClearSight Finger Cuff Medium Multi Pack||CSCM|
|ClearSight Finger Cuff Large Multi Pack||CSCL|
|EV1000 Clinical Platform NI||EV1000NI|
Connectivity via IFM out through a serial connection, HL7 through an Ethernet connection or HL7 integration engine.
The ClearSight system offers continuous clinical decision support to enable proactive clinical decisions for your moderate- to high-risk surgical patients and patients at risk for complications.
The ClearSight system provides you access to advanced hemodynamic parameters, including continuous noninvasive blood pressure, allowing you to evaluate early hemodynamic instability and guide appropriate treatment.
Recent studies show associations between intraoperative hypotension and increased risk of acute kidney injury (AKI) and myocardial
injury2-4 — the leading cause of post-operative mortality within 30 days after surgery.2
Prolonged exposures below mean arterial pressure (MAP) thresholds of 65 mmHg are associated with increased risk of myocardial injury and AKI after noncardiac surgery.2 Furthermore studies also show an increased risk of mortality associated with hypotension after noncardiac surgery.5,6
Cleveland Clinic researchers recently showed that continuous noninvasive monitoring reduced the amount of intraoperative hypotension by nearly half (P=0.039). The Research publication indicated early detection of hypotension by continuous hemodynamic monitoring prompts timely remedial actions, thereby reducing intraoperative hypotension.1
Clarity through advanced hemodynamic parameters CO, SV, SVV, and SVR can help you determine if the cause of IOH is preload, afterload, or contractility.
If the underlying cause of hemodynamic instability is related to decreased flow, continuous parameters can help you determine appropriate fluid therapy.
Additionally, continuous monitoring of advanced hemodynamic parameters enables proactive clinical decisions regarding appropriate treatment to augment vascular volume, reduce anesthetic administration, or use vasopressors or inotropes.1
Frank-Starling relationship between preload and stroke volume (SV)
When managing perfusion, stroke volume (SV) can be optimized using the patient’s own Frank-Starling curve.
The patient’s response to a fluid challenge may be assessed by changes in SV, as indicated by location on the curve. Dynamic and flow-based parameters provide a comprehensive hemodynamic assessment and may help guide individualized fluid administration to avoid over and under resuscitation.1
For additional clarity into whether a ventilated patient will respond positively to fluid, stroke volume variation (SVV) has been proven to be a highly sensitive and specific indicator of preload responsiveness.1-4
Advanced hemodynamic parameters provided by the ClearSight system may be used in PGDT protocols. PGDT is a treatment protocol using dynamic and flow-based parameters with the objective of making the appropriate volume management decisions. PGDT can be implemented in a single procedure or as part of a larger initiative such as Enhanced Recovery After Surgery pathways.
The noninvasive ClearSight system allows continuous assessment of your patient’s physiological needs, to help you recognize sepsis and determine fluid responsiveness.1
The ClearSight finger cuff can be used to measure flow-based parameters continuously prior to, during, and after the fluid administration portion of the 3-hour and 6-hour CMS sepsis bundles.
ClearSight system technology is based on two methods: the volume clamp method to continuously measure blood pressure (BP) and the Physiocal method for initial and frequent calibration.
For blood pressure and cardiac output validation studies, download the ClearSight technology overview here.
With a long-term commitment to improving the quality of care for surgical and critical care patients through education, Edwards clinical education meets you no matter where you are in the learning process — with a continuum of resources and tools that continuously support you as you solve the clinical challenges facing you today, and in the future.
Watch videos, explore the Fluid Response Simulator, sign up for eLearnings, and download the Normal Hemodynamic Parameters pocket card.
Take action to reduce the deadly toll of sepsis
Continuous access to your choice of parameters on the EV1000 clinical platform, when used with the noninvasive ClearSight system, enables you to ensure adequate perfusion and proactively manage fluid administration.
Review how to set up and operate the EV1000 clinical platform with the ClearSight system.
We are committed to providing your institution, clinicians and staff with the highest levels of customer service and support to ensure seamless product implementation and ongoing use, including:
Your information has been submitted and a sales representative will be contacting you shortly.
You may also be interested in this short video overview about the Acumen Hypotension Prediction Index software.
Caution: Federal (United States) law restricts this device to sale by or on the order of a physician.
See Instructions For Use (IFU) / Directions For Use (DFU) for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.
Please update to a current version of your preferred browser, this site will perform effectively on the following:Unable to update your browser?
If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility